SCYNEXIS, Inc. (SCYX) is a biotechnology company specializing in research, development, and commercialization of novel drugs for the treatment of infectious diseases. The company focuses on the discovery and development of innovative drugs targeting various types of infectious diseases, including fungal infections and resistant bacteria. SCYNEXIS aims to develop drugs that are effective and safe for patients with infectious diseases and can bring improvements in the treatment of these conditions. The company also conducts clinical trials and collaborates with medical institutions and pharmaceutical companies to further develop and commercialize its drugs. SCYNEXIS, Inc. (SCYX) shares may be an attractive investment opportunity for investors interested in the biotechnology sector and seeking an investment in a company with a focus on developing new drugs for the treatment of infectious diseases.